Literature DB >> 12614911

Adenosine promotes neuronal recovery from reactive oxygen species induced lesion in rat hippocampal slices.

Cláudia G Almeida1, Alexandre de Mendonça, Rodrigo A Cunha, J Alexandre Ribeiro.   

Abstract

Reactive oxygen species (ROS) are believed to be involved in the pathogenesis of several neurological disorders. We now tested whether the endogenous neuroprotective substance, adenosine, attenuates the cell damage induced by ROS. In rat hippocampal slices, the xanthine oxidase (40 mU/ml) plus xanthine (1 mM) (X/XO) system produced a 27.8+/-7.3% (n=3) increase in ROS, measured by fluorimetry with 2',7'-dichlorodihydrofluorescein, a 246.9+/-18.4% (n=6) increase in the release of tritiated adenosine, and a decrease in synaptic transmission that fully recovered after washout. In the presence of the adenosine A(1) receptor selective antagonist, 1,3-dipropyl-8-cyclopentylxanthine (100 nM), X/XO induced a similar inhibition, however synaptic transmission only recovered to 70.7+/-5.8% of control (n=5). The blockade of A(2A) receptors was devoid of effect (n=4). Adenosine is released by ROS-generating systems, and attenuates the deleterious cellular consequences of ROS through A(1) receptor activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614911     DOI: 10.1016/s0304-3940(02)01478-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Purinergic signaling in the inner ear.

Authors:  Jun Ho Lee; Daniel C Marcus
Journal:  Hear Res       Date:  2007-09-29       Impact factor: 3.208

2.  Adenosine receptors: regulatory players in the preservation of mitochondrial function induced by ischemic preconditioning of rat liver.

Authors:  Filipe V Duarte; João A Amorim; Ana T Varela; João S Teodoro; Ana P Gomes; Rodrigo A Cunha; Carlos M Palmeira; Anabela P Rolo
Journal:  Purinergic Signal       Date:  2016-11-15       Impact factor: 3.765

3.  Adenosine production by brain cells.

Authors:  Edwin K Jackson; Shawn E Kotermanski; Elizabeth V Menshikova; Raghvendra K Dubey; Travis C Jackson; Patrick M Kochanek
Journal:  J Neurochem       Date:  2017-04-06       Impact factor: 5.372

Review 4.  The Use of Caffeine by People with Epilepsy: the Myths and the Evidence.

Authors:  Prisca R Bauer; Josemir W Sander
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-14       Impact factor: 5.081

5.  Adenosine receptor ligands protect against a combination of apoptotic and necrotic cell death in cerebellar granule neurons.

Authors:  Amos A Fatokun; Trevor W Stone; Robert A Smith
Journal:  Exp Brain Res       Date:  2007-11-27       Impact factor: 1.972

6.  A cleanroom sleeping environment's impact on markers of oxidative stress, immune dysregulation, and behavior in children with autism spectrum disorders.

Authors:  Scott Faber; Gregory M Zinn; Andrew Boggess; Timothy Fahrenholz; John C Kern; H M Skip Kingston
Journal:  BMC Complement Altern Med       Date:  2015-03-19       Impact factor: 3.659

7.  New approaches to thyroid hormones and purinergic signaling.

Authors:  Gabriel Fernandes Silveira; Andréia Buffon; Alessandra Nejar Bruno
Journal:  J Thyroid Res       Date:  2013-07-17

Review 8.  Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature.

Authors:  Zsolt Kovács; Dominic P D'Agostino; David Diamond; Mark S Kindy; Christopher Rogers; Csilla Ari
Journal:  Front Psychiatry       Date:  2019-05-23       Impact factor: 4.157

9.  Adenosine Receptors Modulate the Exogenous Ketogenic Supplement-Evoked Alleviating Effect on Lipopolysaccharide-Generated Increase in Absence Epileptic Activity in WAG/Rij Rats.

Authors:  Brigitta Brunner; Csilla Ari; Dominic P D'Agostino; Zsolt Kovács
Journal:  Nutrients       Date:  2021-11-15       Impact factor: 5.717

Review 10.  Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases.

Authors:  Zsolt Kovács; Brigitta Brunner; Csilla Ari
Journal:  Nutrients       Date:  2021-06-26       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.